Pentwater Capital Management’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Pentwater Capital Management’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-50,000	Closed	-$1.05M	–	152
2016 Q3	$1.05M	Buy	+50,000	New	+$576K	0.01%	109

Pentwater Capital Management's VTAE Position: Q4 2016 in Review

Pentwater Capital Management sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 50,000 shares — an estimated $1.05M sold.

Pentwater Capital Management first reported a position in VTAE in Q3 2016 and held it in 1 quarter. The position peaked at $1.05M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Pentwater Capital Management reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Pentwater Capital Management sold 50,000 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $1.05M.
Pentwater Capital Management first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2016 and held it in 1 quarter.
Pentwater Capital Management's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $1.05M in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Pentwater Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.